Hepatoblastoma

Questions discussed in this category

How would you approach the prevention of irinotecan-induced diarrhea in a patient who previously experienced a diffuse rash with cefixime?

What alternatives to cephalosporins would you consider? Do you consider allergy testing?

1 Answer available

Papers discussed in this category

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001 Aug

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Related Topics